Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Journal of Nanoscience and Nanotechnology|September 17, 2015
Diamine Functionalized Cubic Mesoporous Silica for Ibuprofen Controlled DeliveryJ Sivaguru, M Selvaraj, S Ravi, et al.
Radiology|November 14, 1997
Primary non-Hodgkin lymphoma of the large bowelM J Cho, C S Ha, P K Allen, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 23, 1999
Effects of 2-bromopropane on spermatogenesis in the Sprague-Dawley ratH Y Son, Y B Kim, B H Kang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2001
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatmentC E Pelloski, R B Wilder, C S Ha, et al.
International Journal of Immunopharmacology|December 1, 1995
Role of metabolism in ethyl carbamate-induced suppression of antibody response to sheep erythrocytes in female Balb/C miceT C Jeong, S W Cha, J I Park, et al.
Protein Expression and Purification|September 25, 1999
Production of "authentic" poliovirus RNA-dependent RNA polymerase (3D(pol)) by ubiquitin-protease-mediated cleavage in Escherichia coliD W Gohara, C S Ha, S Kumar, et al.
International Journal of Radiation Oncology, Biology, Physics|July 13, 2000
The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinumL N Nguyen, C S Ha, M Hess, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2001
Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failureZ Liao, C S Ha, M T Vlachaki, et al.
Cancer|September 26, 2001
Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphomaC S Ha, S L Tucker, A I Blanco, et al.
Cancer|June 20, 2001
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphomaR B Wilder, M A Rodriguez, C S Ha, et al.
Pageof 8